Mosby's 2014 Nursing Drug Reference (247 page)

BOOK: Mosby's 2014 Nursing Drug Reference
13.66Mb size Format: txt, pdf, ePub

Canada only   Side effects:
italics
= common;
bold
= life-threatening   
Nurse Alert

loratadine (
OTC
, Rx)

(lor-a′ti-deen)

Alavert, Claritin, Claritin Children’s, Claritin RediTabs, Clear-Atadine, Dimetapp, Equaline Non-Drowsy, Equate Allergy Relief, Good Sense Non-Drowsy, Leader Allergy Relief, Tavist ND, Wal-itin Aller-Melts, Wal-vert

Func. class.:
Antihistamine, 2nd generation

Chem. class.:
Selective histamine (H
1
)-receptor antagonist

Do not confuse:
loratadine
/lovastatin/LORazepam/losartan

ACTION:

Binds to peripheral histamine receptors, thereby providing antihistamine action without sedation

USES:

Seasonal rhinitis, chronic idiopathic urticaria for those ≥2 yr

CONTRAINDICATIONS:

Hypersensitivity, acute asthma attacks, lower respiratory tract disease

Precautions:
Pregnancy (B), breastfeeding, increased intraocular pressure, bronchial asthma, hepatic/renal disease

DOSAGE AND ROUTES
Calculator

• Adult and child ≥6 yr:
PO
10 mg/day

• Child 2-5 yr:
PO
5 mg/day

Renal/hepatic dose

• Adult:
PO
CCr <30 ml/min or hepatic disease, 10 mg every other day

Available forms:
Tabs 10 mg; rapid-disintegrating tabs 10 mg; orally disintegrating tabs 10 mg; syr 1 mg/ml; susp 5 mg/ml, ext rel tab 10 mg

Administer:

• 
Rapid-disintegrating tabs
by placing on tongue, to be swallowed after disintegrated with/without water

• 
Use within 6 mo of opening pouch and immediately after opening blister pack

• 
On empty stomach daily

Ext Rel Tab

• 
Do not break, crush, or chew

SIDE EFFECTS

CNS:
Sedation (more common with increased doses), headache, fatigue, restlessness

EENT:
Dry mouth

PHARMACOKINETICS

Onset 1-3 hr, peak 8-10 hr, duration 24 hr, metabolized in liver to active metabolites, excreted in urine, active metabolite desloratadine half-life 20 hr

INTERACTIONS

Increase:
antihistamine effects—MAOIs

Increase:
CNS depressant effects—alcohol, antidepressants, other antihistamines, sedative/hypnotics

Increase:
loratadine level—cimetidine, ketoconazole, macrolides (clarithromycin, erythromycin)

Drug/Lab Test

False negative:
skin allergy tests (discontinue antihistamine 3 days before testing)

NURSING CONSIDERATIONS
Assess:

• 
Allergy:
hives, rash, rhinitis; monitor respiratory status

Perform/provide:

• 
Storage in tight container at room temp

Evaluate:

• 
Therapeutic response: absence of running or congested nose, other allergy symptoms

Teach patient/family:

• 
To avoid driving, other hazardous activities if drowsiness occurs

• 
To avoid use of other CNS depressants

Canada only   Side effects:
italics
= common;
bold
= life-threatening   
Nurse Alert

LORazepam (Rx)

(lor-a′ze-pam)

Ativan

Func. class.:
Sedative, hypnotic; antianxiety

Chem. class.:
Benzodiazepine, short acting

 

Controlled Substance Schedule IV

Do not confuse:
LORazepam
/ALPRAZolam/clonazePAM

ACTION:

Potentiates the actions of GABA, especially in the limbic system and the reticular formation

USES:

Anxiety, irritability with psychiatric or organic disorders, preoperatively; insomnia; adjunct for endoscopic procedures, status epilepticus

Unlabeled uses:
Antiemetic before chemotherapy, rectal use, alcohol withdrawal, seizure prophylaxis, agitation, insomnia, sedation maintenance

CONTRAINDICATIONS:

Pregnancy (D), breastfeeding, hypersensitivity to benzodiazepines, benzyl alcohol; closed-angle glaucoma, psychosis, history of drug abuse, COPD, sleep apnea

Precautions:
Children <12 yr, geriatric patients, debilitated, renal/hepatic disease, addiction, suicidal ideation, abrupt discontinuation

DOSAGE AND ROUTES
Calculator
Anxiety

• Adult/adolescent:
PO
2-3 mg/day in divided doses, max 10 mg/day

• Geriatric:
PO
1-2 mg/day in divided doses or 0.5-1 mg at bedtime

Preoperatively

• Adult:
IM
50 mcg/kg 2 hr prior to surgery;
IV
44 mcg/kg 15-20 min prior to surgery, max 2 mg 15-20 min prior to surgery

• Child ≥12 yr:
IV
0.05 mg/kg

Status epilepticus

• Neonate:
IV
0.05 mg/kg

• Child:
IV
0.1 mg/kg up to 4 mg/dose;
RECT
(unlabeled) 0.05-0.1 mg × 2; wait 7 min before giving 2nd dose

Alcohol withdrawal (unlabeled)

• Adult:
PO
2 mg q6hr × 4 doses then 1 mg q6hr for 8 doses

Insomnia (unlabeled)

• Adult:
PO
2-4 mg at bedtime; only minimally effective after 2 wk continuous therapy

• Geriatric:
PO
0.5-1 mg initially

Available forms:
Tabs 0.5, 1, 2 mg; inj 2, 4 mg/ml; conc oral sol 2 mg/ml

Administer:
PO route

• 
With food or milk for GI symptoms; crushed if patient is unable to swallow medication whole

• 
Sugarless gum, hard candy, frequent sips of water for dry mouth

• 
Give largest dose before bedtime if giving in divided doses

• 
Concentrate:
use calibrated dropper; add to food/drink; consume immediately

IM route

• 
Deep into large muscle mass

• 
Use this route when IV is not feasible

Direct IV route

• 
Prepare immediately before use; short stability time

• 
IV after diluting in equal vol sterile water, 5% dextrose, or 0.9% NaCl for inj; give through
Y
-tube or 3-way stopcock; give at ≤2 mg/1 min, do not give rapidly

• 
Do not use in neonates (benzyl alcohol)

Y-site compatibilities:
Acyclovir, albumin, allopurinol, amifostine, amikacin, amoxicillin, amoxicillin/clavulanate, amphotericin B cholesteryl, amsacrine, atenolol, atracurium, bivalirudin, bleomycin, bumetanide, butorphanol, calcium chloride/gluconate, CARBOplatin,
ceFAZolin, cefepime, cefotaxime, cefoTEtan, cefOXitin, cefTAZidime, ceftizoxime, ceftobiprole, cefTRIAXone, cefuroxime, chloramphenicol, chlorproMAZINE, cimetidine, ciprofloxacin, cisatracurium, CISplatin, cladribine, clindamycin, cloNIDine, cyclophosphamide, cycloSPORINE, cytarabine, DACTINomycin, DAPTOmycin, dexamethasone, dexmedetomidine, diltiazem, DOBUTamine, DOCEtaxel, DOPamine, doripenem, DOXOrubicin, DOXOrubicin liposomal, droperidol, enalaprilat, ePHEDrine, EPINEPHrine, epirubicin, eptifibatide, erythromycin, esmolol, etomidate, famotidine, fenoldopam, fentaNYL, filgrastim, fluconazole, fludarabine, fosphenytoin, furosemide, ganciclovir, gatifloxacin, gemcitabine, gentamicin, glycopyrrolate, granisetron, haloperidol, heparin, hydrocortisone, HYDROmorphone, hydrOXYzine, ifosfamide, inamrinone, insulin (regular), irinotecan, isoproterenol, ketorolac, labetalol, lidocaine, linezolid, magnesium sulfate, mannitol, mechlorethamine, melphalan, meropenem, metaraminol, methadone, methotrexate, methyldopate, methylPREDNISolone, metoclopramide, metoprolol, metroNIDAZOLE, micafungin, midazolam, milrinone, minocycline, mitoXANtrone, morphine, mycophenolate, nafcillin, nalbuphine, naloxone, nesiritide, niCARdipine, nitroglycerin, nitroprusside, norepinephrine, octreotide, oxaliplatin, oxytocin, PACLitaxel, palonosetron, pamidronate, pancuronium, PEMEtrexed, pentamidine, PENTobarbital, PHENobarbital, piperacillin, piperacillin-tazobactam, polymyxin B, potassium chloride, propofol, ranitidine, remifentanil, tacrolimus, teniposide, theophylline, thiotepa, ticarcillin, ticarcillin-clavulanate, tigecycline, tirofiban, tobramycin, TPN, trastuzumab, trimethobenzamide, trimethoprim-sulfamethoxazole, vancomycin, vasopressin, vecuronium, verapamil, vinCRIStine, vinorelbine, voriconazole, zidovudine

SIDE EFFECTS

CNS:
Dizziness, drowsiness
, confusion, headache, anxiety, tremors, stimulation, fatigue, depression, insomnia, hallucinations, weakness, unsteadiness

CV:
Orthostatic hypotension
,
ECG changes, tachycardia,
hypotension;
apnea, cardiac arrest (IV, rapid)

EENT:
Blurred vision
, tinnitus, mydriasis

GI:
Constipation, dry mouth, nausea, vomiting, anorexia, diarrhea

INTEG:
Rash, dermatitis, itching

MISC:
Acidosis

PHARMACOKINETICS

Metabolized by liver; excreted by kidneys; crosses placenta, excreted in breast milk; half-life 42 hr (neonates), 10.5 hr (older child), 12 hr (adult), 91% protein bound

PO:
Onset 1/2 hr, peak 1-6 hr, duration 12-24 hr

IM:
Onset 15-30 min, peak 1-1½ hr, duration 6-8 hr

IV:
Onset 5-15 min, peak unknown, duration 6-8 hr

INTERACTIONS

Increase:
LORazepam effects—CNS depressants, alcohol, disulfiram

Decrease:
LORazepam effects—valproic acid, oral contraceptives

Drug/Herb

Increase:
CNS depression—chamomile, kava, valerian

Drug/Lab Test

Increase:
AST, ALT

NURSING CONSIDERATIONS
Assess:

 
Anxiety:
decrease in anxiety; mental status: mood, sensorium, affect, sleeping pattern, drowsiness, dizziness, suicidal tendencies

• 
Renal/hepatic/blood status if receiving high-dose therapy

• 
Physical dependency, withdrawal symptoms:
headache, nausea, vomiting, muscle pain, weakness, tremors, seizures, after long-term, excessive use

Perform/provide:

• 
Assistance with ambulation during beginning therapy, since drowsiness, dizziness occurs

• 
Check to confirm that PO medication has been swallowed

• 
Refrigerate parenteral form

Evaluate:

• 
Therapeutic response: decreased anxiety, restlessness, insomnia

Teach patient/family:

• 
That product may be taken with food

• 
Not to use product for everyday stress or for >4 mo unless directed by prescriber

• 
Not to take more than prescribed amount; may be habit forming

• 
To avoid OTC preparations (cough, cold, hay fever) unless approved by prescriber

• 
To avoid driving, activities that require alertness, since drowsiness may occur

• 
To avoid alcohol, other psychotropic medications unless directed by prescriber

• 
Not to discontinue medication abruptly after long-term use

• 
To rise slowly because fainting may occur, especially among geriatric patients

• 
That drowsiness may worsen at beginning of treatment

• 
To notify prescriber if pregnancy is planned or suspected, pregnancy (D), do not breastfeed

TREATMENT OF OVERDOSE:

Lavage, VS, supportive care, flumazenil

Other books

Blind Dating: by Taylor, Kerry
Blessings by Kim Vogel Sawyer
Profile of Terror by Grace, Alexa
The Night Watcher by Lutz, John
A Wee Christmas Homicide by Kaitlyn Dunnett
The Perfect Gift by Kathleen Brooks